+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
ID07111169

Study of Brain Stimulation to Improve Attention in Adults With Major Depressive Disorder Using EEG and MRI Guidance

Led by University of Electronic Science and Technology of China · Updated on 2025-08-08

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether stimulating the left dorsolateral prefrontal cortex DLPFC with intermittent theta burst stimulation iTBS can improve cognitive control and reduce attention problems in people with Major Depressive Disorder MDD. This study compares brain stimulation guided by MRI-based neuronavigation to a manual method called the Beam F3 method to see which better affects attention and brain activity in MDD. The trial is double-blind and sham-controlled, involving behavioral tests and EEG measurements to understand the brain mechanisms involved. Participants are randomly assigned to one of two groups the active group receives MRI-guided iTBS targeting the left DLPFC, while the sham group receives stimulation using the Beam F3 manual method. The iTBS treatment involves 20-minute sessions twice a day for five days a week over two weeks, totaling 10 days of treatment. The active groups stimulation uses a neuro-modulation protocol with precise coil positioning guided by MRI, while the sham group uses a standardized cap placement method. During the study, participants complete behavioral tasks and EEG recordings before and after the two-week treatment to measure changes in attention and brain activity. Depression severity is assessed 60 to 90 minutes before the first and after the last iTBS treatments. Researchers also analyze changes in brain connectivity and event-related potentials related to the cognitive tasks. The study runs from January 2024 to December 2028 and involves careful monitoring and comparisons between the two stimulation methods to evaluate their impact on selective attention in MDD.

CONDITIONS

Brief Title

Neuromodulation and Attention Deficits in MDD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here